Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Skin equivalent graft genetically corrected with a COL7A1-encoding SIN retroviral vector

EU orphan designation number: EU/3/09/630   
Active ingredient: Skin equivalent graft genetically corrected with a COL7A1-encoding SIN retroviral vector
Indication: Treatment of dystrophic epidermolysis bullosa
Sponsor: Prof. Alain Hovnanian
Department of Genetics, Inserm UMR 1163, Laboratory of Genetic skin diseases, University Paris Descartes – Sorbonne Paris Cité/Imagine Institute 2nd floor, 24 boulevard du Montparnasse, 75015 Paris, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/05/2009 Centralised Orphan - Designation EMEA/OD/099/08 (2009)3528 of 30/04/2009
27/03/2014 Centralised Orphan - Change of address